In her new role, Dr. Berger will directly report to chief executive officer Jeff Kiplinger and is expected to contribute broadly to Averica's growth and development.
“We are excited to welcome Cindy, who will provide significant insight and guidance to our growth as an analytical development company,” said Dr. Kiplinger. “Cindy will be exploring new ways to expand our capabilities and enhance the value we bring to clients. She will also oversee the standardization of many of our processes as we move toward ISO 17025 certification and add GMP analytical capabilities. Her significant experience and strong understanding of the analytical services market, coupled with her strong operations, financial, and business background, make her an essential asset to the future of Averica.”
Prior to joining Averica Discovery, Dr. Berger served as project manager at PCI Synthesis, a contract manufacturing organization (CMO), where she managed multimillion dollar projects manufacturing active pharmaceutical ingredients.